CONNECTING
stakeholder communities
with innovative therapies.

Focusing on proof-of-concept studies
targeting patients requiring iPS cell therapies,
having cancer or intractable diseases.

Ki-CONNECT Now

Learn more

Early Clinical Studies in Ki-CONNECT

Clinical Studies Department Phase Recruitment Status
Analyzing the Impact of Aging on the Immune System in the Context of COVID-19 Vaccination *Center for iPS Cell Research and Application/Early Clinical Development Clinical Research Active, not recruiting
Investigation of Colorectal Cancer-Related Genes Using Peripheral Blood in Healthy Volunteers *Early Clinical Development/Clinical Oncology Clinical Research Active, not recruiting
A Clinical Study for Treatment of Articular Cartilage Damage in Knee Joints With Allogeneic Induced Pluripotent Stem (iPS) Cell-derived Cartilage (TACK-iPS) *Orthopaedic Surgery Regenerative Medicine, Clinical Research Active, not recruiting
A Phase 1 first in human study evaluating safety, pharmacokinetics and efficacy of ABBV-400 in adult subjects with advanced solid tumors *Early Clinical Development/Clinical Oncology/Gastroenterology and Hepatology/Respiratory Medicine Ⅰ Enrolling by invitation
An Open-Label, Dose Escalation, Phase 1, First-in Human Study of TAK-102 in Adult Patients With GPC3-Expressing Previously Treated Solid Tumors *Early Clinical Development/Hepatobiliary Pancreatic Surgery and Transplantation/Gastroenterology and Hepatology Ⅰ Enrolling by invitation
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors *Early Clinical Development/Breast Surgery Ⅰ Enrolling by invitation
Study of DSP-0390 in Patients With Recurrent High-grade Glioma *Neurosurgery Ⅰ Enrolling by invitation
An open-label pharmacokinetic study of TS-142 in patients with hepatic impairment *Early Clinical Development Ⅰ Enrolling by invitation
A Phase 1 Study of Lomustine and PCV in Japanese Patients with Glioma (LOMG) *Neurosurgery Ⅰ Enrolling by invitation
Phase I/II trial for safety and pharmacokinetics of ENDOPIN in healthy and patients with postoperative pain *Early Clinical Development/Thoracic Surgery Ⅰ-Ⅱ Enrolling by invitation
Multicenter Phase II Investigator-Initiated Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy with Immune Checkpoint Inhibitors and Photodynamic Therapy for Esophageal and Gastric Cancer *Clinical Oncology Ⅰ-Ⅱ Enrolling by invitation
Nivolumab and Chemoradiotherapy for Esophageal Cancer *Clinical Oncology Ⅰ-Ⅱ Active,not recruiting
Study of Sacituzumab Govitecan in Japanese Patients with Advanced Solid Tumors or Triple-negative Breast Cancer *Breast Surgery Ⅰ-Ⅱ Enrolling by invitation
Learn more

Message

On the occasion of opening of Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy
April 6, 2020　Shinya Yamanaka

Learn more

Our vision

From Kyoto to the World, and to the Next Generation

We will create breakthroughs in medicine by developing the world’s most advanced basic science,
medical technologies and regenerative medicine with iPS cells originated from Kyoto University.

To those who participate in clinical trials

We respond to you who want to do something for patients waiting for new medicines and for the next-generation medical care.

To development personnel

We can conduct early clinical trials in a variety of disease areas with the support of many clinical departments at Kyoto University Hospital, and provide a strict and high-quality clinical trial settings that is unique to Academia.

To researchers in medical and research institutions

We facilitate speedy and stress-free implementation of early clinical trials through resolving the bothersome tasks.

Facilities

A hospital ward dedicated to early clinical development

A hospital ward dedicated to early clinical development, with a clinical trial management department and a Clinical Bio-Resource Center for collecting and managing clinical specimens, which combines clinical trial functions and research functions.

Learn more

Our team

Total support for early clinical development.

Full-time physicians, CRCs, nurses, pharmacists, laboratory technicians, and administrative staff provide total support for early clinical development.

- Under the ward management through cooperation between related clinical departments and full-time physicians for the center, and the emergency system to prepare for the occurrence of adverse events, early clinical trials with high risk can be conducted.
- Support for physiological examinations from staff with expertise in clinical research
- Total support from office staff familiar with clinical research

Meet the team

What we do

Strict and high-quality clinical trial settings unique to Academia

With the support of medical staff familiar with early clinical trials and many departments of Kyoto University Hospital, early clinical trials can be conducted in a variety of disease areas.

Learn more

Get in touch

Consultation for Investigator-initiated Clinical Trials
Contact for Sponsor-initiated Clinical Trials

Please fill out the form and transmit your inquiry.Inquiry form

HomeA clinical research aims to analyze the impact of aging on the immune system in the context of covid-19 vaccination has started.

Copyright © Kyoto University Hospital. All Rights Reserved.